Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560885 · ClinicalTrials.gov registry record · Phase 3
AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation
A Phase 3 study, sponsored by AtriCure.
- Completed
- Registry status
- Phase 3
- Development phase
- 55
- Enrollment target
NCT00560885: Completed Phase 3 study, sponsored by AtriCure.
NCT00560885 is a Phase 3 study that has completed, run by AtriCure. The registered enrollment target is 55 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00560885, a Phase 3 study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 55 participants
- Enrollment target
Study Summary
ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.
Interventions
- DEVICE AtriCure Bipolar System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
What the finished NCT00560885 record still lists
NCT00560885 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which AtriCure Bipolar System is the first listed.
NCT00560885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00560885 about?
NCT00560885 is a clinical study titled "AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation". ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.
What is the current status of trial NCT00560885?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 55 participants. The study started on 2007-11. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00560885?
The interventions under investigation include: AtriCure Bipolar System (DEVICE).
Who is sponsoring clinical trial NCT00560885?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00560885's enrollment target sits among peer trials
55 1834th of 2000 higher than 163 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia